[1] TANG L H, PEI H F, YANG Y, et al. The inhibition of calpains ameliorates vascular restenosis through MMP2/TGF-β1 pathway[J]. Sci Rep, 2016, 6:29975.
[2] TRIAS B, MERIGHI A.Capsaicin, nociception and pain[J]. Molecules, 2016, 21(6):797.
[3] 王欣, 石汉平.辣椒素的摄取、代谢与生物学效应[J]. 肿瘤代谢与营养电子杂志, 2018, 5(4):419-423.
[4] LIU R, HEISS E H, GUO D, et al. Capsaicin from chili(Capsicum spp.) inhibits vascular smooth muscle cell proliferations[J]. F1000Res, 2015, 4:26.
[5] 汪小英, 彭维杰, 罗丹.TRPV1的血管生物学作用及与血管性疾病关系的研究进展[J]. 南昌大学学报(医学版), 2018, 58(6):81-85.
[6] BASITH S, CUI M, HONG S, et al. Harnessing the therapeutic potential of capsaicin and its analogues in pain and other diseases[J]. Molecules, 2016, 21(8):966.
[7] ANGGRAHINI D W, EMOTO N, NAKAYAMA K, et al. Vascular endothelial cell-derived endothelin-1 mediates vascular inflammation and neointima formation following blood flow cessation[J]. Cardiovasc Res, 2009, 82(1):143-151.
[8] 蔡振东, 胡凯, 刘宗军.冠心病患者药物支架内再狭窄的影响因素分析[J]. 实用医学杂志, 2017, 33(17):2904-2906.
[9] 孙晓骥.各型冠脉介入支架特点及再狭窄机制的研究进展[J]. 中国医疗器械信息, 2019, 25(6):18-19.
[10] GLADING A, LAUFFENBURGER D A, WELLS A.Cutting to the chase:calpain proteases in cell motility[J]. Trends Cell Biol, 2002, 12(1):46-54.
[11] SHARMA S K, VIJ A S, SHARMA M.Mechanisms and clinical uses of capsaicin[J]. Eur J Pharmacol, 2013, 720(1-3):55-62.
[12] LI J, WANG D H.Function and regulation of the vanilloid receptor in rats fed a high salt diet[J]. J Hypertens, 2003, 21(8):1525-1530.
[13] MA L, ZHONG J, ZHAO Z, et al. Activation of TRPV1 reduces vascular lipid accumulation and attenuates atherosclerosis[J]. Cardiovasc Res, 2011, 92(3):504-513.
[14] MUÑOZ-ISLAS E, GONZÁLEZ-HERNÁNDEZ A, LOZANO-CUENCA J, et al. Inhibitory effect of chronic oral treatment with fluoxetine on capsaicin-induced external carotid vasodilatation in anaesthetised dogs[J]. Cephalalgia, 2015, 35(12):1041-1053.
[15] ZHANG M J, LIU Y, HU Z C, et al. TRPV1 attenuates intracranial arteriole remodeling through inhibiting VSMC phenotypic modulation in hypertension[J]. Histochem Cell Biol, 2017, 147(4):511-521.
[16] PANCHAL S K, BLISS E, BROWN L.Capsaicin in Metabolic Syndrome[J]. Nutrients, 2018, 10(5):630.
[17] ELOKELY K, VELISETTY P, DELEMOTTE L, et al. Understanding TRPV1 activation by ligands:Insights from the binding modes of capsaicin and resiniferatoxin[J]. Proc Natl Acad Sci U S A, 2016, 113(2):E137-145.
[18] SU L, ZHANG Y, HE K, et al. Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury[J]. J Vasc Surg, 2017, 65(1):197-205.e2.
[19] YANG F, ZHENG J.Understand spiciness:mechanism of TRPV1 channel activation by capsaicin[J]. Protein Cell, 2017, 8(3):169-177.
[20] LIAO M, CAO E, JULIUS D, et al. Structure of the TRPV1 ion channel determined by electron cryo-microscopy[J]. Nature, 2013, 504(7478):107-112.
[21] CORDELL G A, ARAUJO O E.Capsaicin:identification, nomenclature, and pharmacotherapy[J]. Ann Pharmacother, 1993, 27(3):330-336.
[22] HONG S, AGRESTA L, GUO C, et al. The TRPV1 receptor is associated with preferential stress in large dorsal root ganglion neurons in early diabetic sensory neuropathy[J]. J Neurochem, 2008, 105(4):1212-1222.
[23] JAGGI A S, SINGH N.Mechanisms in cancer-chemotherapeutic drugs-induced peripheral neuropathy[J]. Toxicology, 2012, 291(1-3):1-9.
[24] REHMAN R, BHAT Y A, PANDA L, et al. TRPV1 inhibition attenuates IL-13 mediated asthma features in mice by reducing airway epithelial injury[J]. Int Immunopharmacol, 2013, 15(3):597-605. |